GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/Malignant Oesophagal Stricture With Airway Involvement: Check the Airway Before You Stent: FG | October 2026
7

Malignant Oesophagal Stricture With Airway Involvement: Check the Airway Before You Stent: FG | October 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated October 1, 2026

What Did the Study Find?

This tertiary-centre study evaluated 26 patients with malignant oesophagal strictures undergoing same-session upper GI endoscopy and bronchoscopy because of suspected oesophageal–airway involvement.

  • 81% had oesophagal cancer and 19% had lung cancer; most had advanced disease.
  • Although dysphagia was the commonest referral symptom (42%), CT already demonstrated airway compromise in 65%—often without prominent respiratory symptoms.
  • Endoscopy identified an esophago-airway fistula in 46%, despite only 23% being referred with a known fistula.
  • Treatment consisted of esophageal stenting alone in 35%, airway stenting alone in 19%, and dual stenting in 27%.
  • All patients receiving airway intervention had >50% airway stenosis.
  • Critically, after esophageal stenting as the initial intervention, immediate repeat bronchoscopy showed worsening airway compression in one-third of patients.
  • New esophago-airway fistula was an important post-stenting complication, occurring in 19% of patients receiving a stent.
  • Half required a subsequent endoscopic or bronchoscopic procedure.
  • Prognosis was extremely poor: median survival after the combined assessment was only 1.9 weeks.

A Practical Algorithm Emerges

For malignant esophageal strictures with suspected airway involvement:

CT assessment → multidisciplinary GI/respiratory review → bronchoscopy first → esophageal intervention when appropriate → repeat bronchoscopy immediately after esophageal stenting.

If airway narrowing is <50% without fistula**, esophageal stenting alone can generally be considered. With **>50% airway compromise or an esophago-airway fistula, airway and/or dual stenting should be considered. If esophageal stenting creates new severe airway compression, airway stenting or reversal of the esophageal intervention may be required.

Why Does It Matter?

An esophageal stent can relieve dysphagia but its radial force can convert a partially compromised airway into clinically important obstruction. Respiratory symptoms alone are therefore insufficient to identify risk.

GastroAGI Takeaway

In malignant esophageal stenosis, look beyond the esophageal lumen before placing the stent. If CT suggests airway involvement, the safest strategy may be planned same-session bronchoscopy and upper-GI endoscopy, ideally in a tertiary center with both interventional teams available.

The particularly important procedural lesson is: bronchoscopy before—and again after—esophageal stenting.

Related Q&A

08

IBS Beyond the Gut–Brain Axis: Is Triglyceride Biology Part of the Story?: Gut | September 2026

What Did the Study Find? The largest genetic study of IBS to date analyzed ~2.8 million individuals across 22 international biobanks, integrating different IBS definitions and subtypes. Researchers...

09

Appendiceal Adenocarcinoma Is Not Colon Cancer: JAMA Surgery | September 2026

What Did the Study Find? This large study evaluated 439 patients with stage I–III appendiceal adenocarcinoma, with external validation and median follow-up exceeding 5 years. Relapse after curative...

10

STARS Phase III: Once-Weekly Apraglutide Reduces Parenteral-Support Dependence in Short-Bowel Syndrome: CGH | September 2026 | Phase III STARS Trial

Introduction: Patients with short-bowel syndrome with intestinal failure (SBS-IF) may require long-term parenteral support, creating substantial treatment burden and catheter-related risks. STARS evaluated apraglutide, a once-weekly GLP-2 analogue,...

11

Can Brain Stimulation Reduce Visceral Pain in IBS-D? Low-Frequency rTMS Shows Promise: Gut | September 2026

Introduction: Chronic visceral pain is one of the most difficult symptoms to treat in diarrhea-predominant IBS (IBS-D). This translational study identified medial prefrontal cortex (mPFC) hyperexcitability as a...

12

ACG Updates the Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes: AJG | September 2026

Introduction: Hereditary adenomatous polyposis syndromes are systemic cancer-predisposition disorders involving not only the colorectum but also the stomach, duodenum and other organs. The updated ACG guideline emphasises earlier...

13

IBD in Remission but Symptoms Persist (Rome Foundation–IOIBD Consensus): Gastroenterology | September 2026

Introduction: Up to one-third of patients with IBD report abdominal pain, altered bowel habits or bloating despite treatment, and approximately one-quarter remain symptomatic even in endoscopic or histologic...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer